Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q1 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.